DPN Dr. Kaustabh Ghosh In this episode of the Doheny Podcast Network, a conversation with Doheny researcher, Dr. Kaustabh Ghosh. He talks about his expertise in biomechanics and how tackling big questions in cardiac care led him to ophthalmology, where he is leading an innovative lab. Dr. Anne Coleman The Doheny Podcast Network returns with this conversation with glaucoma specialist Dr. Anne Coleman of UCLA Stein Eye Institute. Dr. Coleman talks about her year as President of the American Academy of Ophthalmology, and as the COVID-19 pandemic unfolds, how it is affecting patients, doctors and vision science research. The Fragile Eyesight of Premature Babies A conversation with Irena Tsui, MD of Doheny-UCLA and Alison Chu, MD, neonatologist at UCLA about preserving the fragile eyesight of premature babies. Dr. SriniVas Sadda and Dr. Deborah Ferrington A conversation with Doheny Eye Institute’s Dr. Vas Sadda and Dr. Deborah Ferrington about the work of the Ryan Initiative for Macular Research ahead of RIMR’s 12th annual conference. Treating Cancer Patients with Eye Disease In this conversation, Dr. Olivia Lee and Dr. John Irvine discuss the collaboration between Doheny Eye Institute and City of Hope, consulting on graft-vs-host disease (GVHD) in patients suffering from symptoms that affect their eyesight. Innovations in the Treatment of Polypoidal Choroidal Vasculopathy A conversation with Dr. Micheal Ip, Director of the Doheny Image Reading Center, and Dr. Gemmy Cheung, head of the Retina Research Group at the Singapore Eye Research Institute. Advancing Diagnostics for Glaucoma and Retinal Disease with AI A conversation with Dr. Alex Huang, Doheny-UCLA research-scientist, and Dr. Naama Hammel, Clinical Research Scientist at Google Artificial Intelligence Healthcare. Corneal Cross-Linking and its Potential Promise A conversation with Dr. Benjamin Bert, and Doheny-UCLA clinical fellow, Dr. Arpine Barsegian about corneal collagen cross-linking, a breakthrough procedure for patients with thinning corneas. Artificial Intelligence (AI) at Doheny Artificial Intelligence (AI) at Doheny: Learn about AI as an emerging and exciting tool to aid in diagnosing ocular disease as well as its capabilities to link disease prevention, treatment and patient outcomes. Ideal Candidates For Clinical Trials A conversation about clinical trials with Dr. Alfredo Sadun. Patients in treatment often ask about participation in these drug tests. Dr. Sadun explains how doctors and researchers decide who makes a good candidate for a clinical trial, how to ensure a trial is legitimate, and the impact of clinical trial research on his own work throughout his career in neuro-ophthalmology. Newest therapies, drug delivery options, and the best ways to get involved with stem cell trials. A conversation with Dr. Ali Khan about the newest therapies, and drug delivery options for patients with wet Age-related Macular Degeneration, and the best ways to get involved with stem cell trials. Steven Barnes, PhD, shares how physicians will deliver earlier treatments for those with retinal disease. Dr. Barnes shares how the cells in the retina are vital to show disease and its progression. His work to study these cells and the signals they provide will allow physicians to deliver earlier treatments for those with retinal disease. Advances in technology can enhance patient care globally David Garway-Heath, MD, FRCOphth, President of the European Glaucoma Society, and Alex Huang, MD, PhD discuss how advances in technology and collaboration continuously enhance patient care globally. Exceptional Outcome for Cornea Transplant Patient How one savvy patient partnered with a Doheny doctor to pursue cutting edge treatment to save her sight. A conversation with television producer Lauren Dascher, and Dr. Olivia Lee. A conversation with Ken Marion A conversation with Ken Marion, Program Manager at the Doheny Image Reading Center Research Lab. Insights into how Doheny collaborates with medical device makers and other industry innovators, conducts state of the art imaging research and hosts an international cohort of leading ophthalmologists working to advance vision research. Mission to Mexico Dr. Francis discusses his visit to Fuerte, Mexico, where he performed dozens of pro bono surgeries for patients at a rural clinic. A conversation with James Jorkasky & Dr. Alex Huang A conversation about vision science research funding with James Jorkasky, Executive Director of the National Alliance of Eye and Vision Research in Washington, D.C., and Doheny Dr. Alex Huang. Dr. David Sarraf A conversation about emerging imaging technologies in vision care with Dr. David Sarraf of the UCLA Stein Eye Institute. Dr. Tara McCannel A conversation with ocular cancer specialist Dr. Tara McCannel, Director of the Ophthalmic Oncology Center at UCLA Stein Eye Institute. Dr. McCannel discusses the evolving technology allowing for earlier detection of small cancers, and how UCLA doctors developed procedures to significantly improve outcomes for patients treated with radiation for melanomas of the eye. Dr. Hugo Hsu A conversation with Dr. Hugo Hsu. Dr. Hsu is an accomplished cornea specialist in his work with patients. Now, he is on the cusp of some very innovative research in the microbiome of the eye's surface, looking for more clues to curing eye disease. Dr. Alex Huang A conversation with Dr. Alex Huang, a convener of the 2nd Annual Doheny-UCLA International Glaucoma Symposium in Los Angeles coming up in October. We discuss hot topics in glaucoma research, and the dynamic regulatory environment. Plus insights into Dr. Huang's own research, including his collaboration with NASA. Dr. Huang was voted the top ophthalmologist in the world by his peers in 2017. Dr. Anne Coleman A conversation with Dr. Anne Coleman of the Stein Eye Institute. Her work addresses issues faced by special populations, including children who visit the UCLA Mobile Eye Clinic, which she directs. Dr. Coleman is also focused on slowing the progression of macular degeneration, a disease which affects elderly patients. Encore Edition Hear two of our most-listened-to episodes in this one encore edition. First, Dr. Olivia Lee and Dr. Laura Vickers share insights from their mission to Mongolia, where they trained colleagues in corneal transplants. Plus, a conversation with Dr. Alfredo Sadun, about advances in gene therapy, and his on-going international research in the quest to cure Leber’s Hereditary Optic Neuropathy. Janet DeMint A conversation with Janet DeMint, director of the Ryan Initiative for Macular Research, a program of the Doheny Eye Institute. DeMint describes the impact the Initiative is having by bringing together scientists with expertise in ophthalmology, stem cell research, and a range of other specialties, resulting hundreds of millions of dollars of funding for interdisciplinary research to cure macular degeneration. Dr. Kenneth Lu A conversation with Dr. Kenneth Lu, a cataract surgeon, and founder of the Doheny Innovation and Entrepreneurship Conference, helping innovators in vision care bring their ideas out of the lab and into the marketplace. Dr. John Irvine A conversation with Dr. John Irvine about topics and presenters featured at this year’s Doheny Days gathering, and the enduring relevance of Continuing Medical Education as critical to informing the work of ophthalmologists at the frontiers of research and patient care. Dr. Monica Khitri A conversation with Dr. Monica Khitri about treatment for the very youngest of children facing compromised vision and eye health challenges. Dr. Khitri discusses surgery options for infants, eyeglasses for toddlers, and her work guiding parents in making choices for their child’s eye care. Dr. Benjamin Bert Dr. Bert is interested in convening conversations across medical disciplines, and is currently designing a trial to make patients undergoing injectable retina treatment more comfortable. Dr. Emily Chew A conversation with Dr. Emily Chew, deputy director of the Division of Epidemiology and Clinical Applications and the deputy clinical director at the National Eye Institute at the National Institutes of Health. Dr. Chew directs studies about the links between diet and macular degeneration. She talks about those findings and other advances in the field. Dr. Michael Ip A conversation with Dr. Michael Ip, Medical Director of the Doheny Image Reading Center, about the critical importance of images, innovation and analysis in improving outcomes for eye patients. Laurie Levin A conversation with Laurie Levin, author of A Clear Vision, published in celebration of Doheny Eye Institute’s 70th Anniversary in 2017. Dr. Brian Francis Dr. Francis discusses the art and science of eye surgery, compassionate patient care and advances in nano-technology for eye patients. Dr. SriniVas Sadda (Part 2) Advances in curing eye disease rely on collaborations and critical communication among colleagues around the globe. Dr. SriniVas Sadda (Part 1) On the frontiers of fighting eye disease: gene therapy, gene editing and innovations in imaging. Mission to Mongolia A conversation with Dr. Olivia Lee and Dr. Laura Vickers talking about their recent trip to Mongolia, where they performed six corneal transplant surgeries and trained colleagues in surgical techniques and follow up care. Gene Therapy Today Dr. Alfredo Sadun explains the latest advances and applications of gene therapy for treating diseases of the eye. Streamlining Retina Screening Dr. Tsui on streamlining retina screening, access to care + advances in pediatric retinopathy. Thyroid Eye Disease, Aesthetics, & Global Standards A conversation with Dr. Daniel Rootman: Thyroid eye disease, aesthetics, and moving toward global standards for orbital surgery. New Glaucoma Surgery Tailored to Each Patient’s Anatomy Doheny Eye Institute’s Alex Huang, MD / PhD, has received a prestigious Research to Prevent Blindness Career Development Grant (2015). His work at the frontiers of customized surgery for glaucoma patients is poised to change approaches to treatment internationally. The impact of Dr. Huang’s work is more than global — listen to him talk about his pending research with NASA.